Hormone receptor–positive breast cancer has been associated with a late recurrence compared with hormone receptor–negative breast cancer; the higher frequency of hormone receptor–positive status in ILC, compared with IDC, may provide a plausible explanation for the observed association of ILC with late recurrence. This evidence concerns the gene NR4A1 and breast carcinoma.